News About: Pharm. Industry
Domestic OTC markers urged to step up public advertisements
Pharmaceutical business sources said that major pharmaceutical OTC manufacturers need to launch more advertising campaigns for OTC products in a bid to increase the frequency of people's pharmacy visits via better pub...
Chlorella and Lyprinol most popular in online markets.
A survey conducted by Yakup Press against 3 leading online shopping malls operating by leading pharmacy franchise companies (Ohnuri, Withpharm and Medion) revealed Chlorella and Lyprinol preparations as the ...
CJ exclusively to distribute Tezalin, anti-rhinitis agent.
CJ pharmaceutical division agreed with Zeller Co., a Swiss pharmaceutical company on July 12 for the exclusive distribution of Tezalin in Korea, a phytochemical drug for the treatment of rhinitis.
Tezalin was deve...
Xenical granted additional indication for treatment of obesity in Korea's children and adolescents
Roche Korea's anti-obesity agent, Xenical (orlistat) has bee granted Korea's weight-loss drug for the treatment of obesity in children and adolescents. There are currently no products on the market for the treatment o...
Top 100 drugs included 74 prescription and 26 non-prescription drugs.
The top 100 finished drugs in 2003 included 74 prescription and 26 non-prescription items according to the 2003 statistics compiled by the KPMA.
The report revealed a new entry of 4 prescription drugs from 70 in 20...
2003 pharmaceutical bulks output outlined
The Korea Pharmaceutical Manufacturers Association said in its report that of top 100 bulk drugs in 2003, five pharmaceutical bulks recorded output of more than 10 billion won compared with seven items in 2002:
- ...
Hyundai Pharm captures mentoring spirit
Hyundai Pharm says it has launched its mentoring programs as part of efforts to meet the company's 2004 vision and management policy towards high value-added creation via R&D new drug projects and nurturing of human r...
Industry to solidify internal management by promotional expense cut-off.
Most of pharmaceutical industries are trying their whole efforts to substantiate their internal management structures by reducing the selling and general administration expenses, especially the promotional and enterta...
Yuhan Corp. introduces novel hepatitis C productYuhan Corp. said on July 12 that it has launched in Korea PegIntron (peginterferon alfa-2b), Schering-Plough's novel pegylated interferon product for the treatment of chronic he...
|
Yuyu Pharm to work with KRICT on joint development of ischemic vascular drugsYuyu Pharm said on July 9 it has signed with the Korea Research Institute of Chemical and Technology a strategic agreement to jointly develop new drugs for the treatment of isch...
|
